CN103564300A - 一种高丽红参蜜片的加工工艺 - Google Patents
一种高丽红参蜜片的加工工艺 Download PDFInfo
- Publication number
- CN103564300A CN103564300A CN201310596438.6A CN201310596438A CN103564300A CN 103564300 A CN103564300 A CN 103564300A CN 201310596438 A CN201310596438 A CN 201310596438A CN 103564300 A CN103564300 A CN 103564300A
- Authority
- CN
- China
- Prior art keywords
- honey
- korean
- sheet
- korea
- ginseng
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 64
- 235000012907 honey Nutrition 0.000 title claims abstract description 64
- 238000012545 processing Methods 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title abstract description 4
- 230000008569 process Effects 0.000 title abstract description 4
- 240000004371 Panax ginseng Species 0.000 claims abstract description 31
- 235000008434 ginseng Nutrition 0.000 claims abstract description 31
- 239000000284 extract Substances 0.000 claims abstract description 20
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims abstract description 10
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims abstract description 10
- 238000010438 heat treatment Methods 0.000 claims abstract description 9
- 238000003756 stirring Methods 0.000 claims abstract description 9
- 238000010025 steaming Methods 0.000 claims description 17
- 238000005516 engineering process Methods 0.000 claims description 16
- 235000009508 confectionery Nutrition 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 8
- 241000206575 Chondrus crispus Species 0.000 claims description 8
- 108010010803 Gelatin Proteins 0.000 claims description 8
- 239000001110 calcium chloride Substances 0.000 claims description 8
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 8
- 229920000159 gelatin Polymers 0.000 claims description 8
- 239000008273 gelatin Substances 0.000 claims description 8
- 235000019322 gelatine Nutrition 0.000 claims description 8
- 235000011852 gelatine desserts Nutrition 0.000 claims description 8
- 238000009413 insulation Methods 0.000 claims description 8
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 8
- 238000002791 soaking Methods 0.000 claims description 8
- 238000010792 warming Methods 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 235000008708 Morus alba Nutrition 0.000 abstract description 12
- 240000000249 Morus alba Species 0.000 abstract description 5
- 244000126002 Ziziphus vulgaris Species 0.000 abstract description 5
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract description 2
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract description 2
- 235000013402 health food Nutrition 0.000 abstract description 2
- 238000012827 research and development Methods 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 16
- 235000013399 edible fruits Nutrition 0.000 description 12
- 230000001093 anti-cancer Effects 0.000 description 9
- 241000218231 Moraceae Species 0.000 description 8
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- -1 carrotene Proteins 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229930192392 Mitomycin Natural products 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- OVYQSRKFHNKIBM-UHFFFAOYSA-N butanedioic acid Chemical compound OC(=O)CCC(O)=O.OC(=O)CCC(O)=O OVYQSRKFHNKIBM-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 229960004857 mitomycin Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 2
- 235000021018 plums Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- DBOVHQOUSDWAPQ-UHFFFAOYSA-N (4aS)-6c-[O2-(3,5,3'-trihydroxy-biphenyl-2-carbonyl)-beta-D-glucopyranosyloxy]-5t-vinyl-(4ar)-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one Natural products OC1C(O)C(CO)OC(OC2C(C3C(C(OCC3)=O)=CO2)C=C)C1OC(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-UHFFFAOYSA-N 0.000 description 1
- STGNLGBPLOVYMA-MAZDBSFSSA-N (E)-but-2-enedioic acid Chemical compound OC(=O)\C=C\C(O)=O.OC(=O)\C=C\C(O)=O STGNLGBPLOVYMA-MAZDBSFSSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FZIPCQLKPTZZIM-UHFFFAOYSA-N 2-oxidanylpropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FZIPCQLKPTZZIM-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- WRYLYDPHFGVWKC-SNVBAGLBSA-N 4-Terpineol Natural products CC(C)[C@]1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-SNVBAGLBSA-N 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- BZXINCMCFVKGKB-UHFFFAOYSA-N Amarogentin Natural products OCC1OC(OC2OC=C3C(CCOC3=O)C2C=C)C(OC(=O)c4cc(O)cc(O)c4c5cccc(O)c5)C(O)C1O BZXINCMCFVKGKB-UHFFFAOYSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000427324 Glinus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 240000005049 Prunus salicina Species 0.000 description 1
- 108091007187 Reductases Proteins 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- DBOVHQOUSDWAPQ-WTONXPSSSA-N amarogentin Chemical compound O([C@H]1[C@H](O[C@H]2[C@@H]([C@H]3C(C(OCC3)=O)=CO2)C=C)O[C@@H]([C@H]([C@@H]1O)O)CO)C(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-WTONXPSSSA-N 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- BHLWLVTYEDJFGZ-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1.O=CC1=CC=CC=C1 BHLWLVTYEDJFGZ-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- KYYWBEYKBLQSFW-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O KYYWBEYKBLQSFW-UHFFFAOYSA-N 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000007688 immunotoxicity Effects 0.000 description 1
- 231100000386 immunotoxicity Toxicity 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- NIFHFRBCEUSGEE-UHFFFAOYSA-N oxalic acid Chemical compound OC(=O)C(O)=O.OC(=O)C(O)=O NIFHFRBCEUSGEE-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
- A23L21/25—Honey; Honey substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Fruits And Vegetables (AREA)
Abstract
本发明所属保健食品研究开发技术领域。本发明涉及一种高丽红参蜜片的加工工艺。挑选韩国产高丽鲜园参5年根100g并洗净;将洗净的韩国产高丽鲜园参切片,将韩国产高丽鲜园参片用蒸锅进行蒸制,将麦芽糖、异麦芽低聚糖溶液、大枣提取物、桑椹提取物和乌梅提取物放入蜂蜜中,加热,搅拌均匀;将经蒸制过的韩国产高丽参片浸蜜,沥干蜂蜜;将经浸过蜜的韩国产高丽参片用蒸锅进行第二次蒸制,将经第二次蒸制过的高丽参片浸蜜,将经浸过蜜的韩国产高丽参片进行干燥,得到表面不粘手的蜜片,软硬适中为宜,装袋或装瓶。本发明产品具有强身健体的功能。
Description
技术领域
本发明所属保健食品研究开发技术领域。本发明涉及一种高丽红参蜜片的加工工艺。本发明产品具有强身健体的功能。
背景技术
1高丽红参系由产自韩国的高丽园参经蒸、烘烤加工而成,在加工高丽红参过程中,有新的抗癌活性成分产生。高丽红参不凉也不热,属于温性;高丽参虽性温但补性强,益气助火。高丽参又分白参和红参,脾虚火旺者宜用白参,因“生用气凉,微苦补阴”;脾虚肺怯者宜用红参,“熟用气温,味甘补阳”。总体来说,高丽参更适合老年气虚症状明显的人服用,能强壮体质,增强免疫力。
高丽红参的功效:
(1)益智健脑:对记忆力减退和运动协调能力下降的人以及经常喝酒或接触带乙醇成分的食物、药物的人,高丽红参具有提高脑力工作能力、增强记忆力和改善脑缺血性障碍的功效
(2)镇痛:一些专家通过做传感神经细胞试验发现,高丽参对身体各种疼痛症状都有所帮助。
(3)防癌和抗癌:高丽红参的皂苷成分和非皂苷成分有抑制多种癌细胞的增殖活性,同时也可抑制癌细胞转移。另外,高丽红参与抗癌剂同服用,抗癌效果要好于单独用抗癌剂(丝裂霉素)。这是因为肿瘤化疗中癌细胞易形成耐受,高丽红参与抗癌剂同服用,增强对癌细胞的杀伤力、减轻抗癌剂的副作用。
(4)增强免疫力:高丽红参提取物可恢复因服用具有免疫毒性的抗癌剂(丝裂霉素)而下降的细胞性免疫反应,尤其乙醚提取物可激活或增强细胞性免疫,及自然杀伤细胞的活性,对提高免疫力有很大的功效。
(5)控制糖尿病:高丽红参含有促进胰岛素分泌和类似胰岛素作用的物质,其中人参皂苷能改善高血糖,有效地控制糖尿病的发生。
(6)健肝:高丽参成分中有抗肝炎活性,具有解毒、保护肝脏及促进肝再生、恢复的作用。此外,高丽红参还有解酒、消除宿醉的作用。
(7)调节血压:高丽红参具有扩张血管作用,能改善血液循环,其中的皂苷成分通过促进血管内皮细胞释放一氧化氮,可达到降血压作用。
(8)抗疲劳及抗压:经研究发现,持续服用高丽红参可以提高运动能力和缓解疲劳,对促进运动员疲劳累积的恢复和预防运动性贫血有很大帮助;此外,高丽红参还可以增强对低温(5℃、O℃、-10℃)及高温(35℃)等不利环境的耐受力,通过对压力或环境变化进行精妙调节,提高抗压能力,维持机体稳定性。
(9)改善女性更年期障碍:据调查,有更年期障碍症状的女性在服用高丽红参后,有80%的人承认服用高丽红参后症状明显改善。专家称,这些女性如根据症状来调整用量,还可提高疗效。
(10)改善男性性功能障碍:高丽红参可防止因压力导致的男性性功能障碍。经临床试验,勃起障碍患者(90人)服用高丽红参后,在勃起程度、性欲及满意度等方面都有所改善。
(11)抗氧化及抗衰老:高丽红参具有抑制有害活性氧的增多和脂类过氧化的抗氧化效果。
2大枣又名红枣、干枣、枣子,起源于中国,在中国已有八千多年的种植历史,自古以来就被列为“五果”(栗、桃、李、杏、枣)之一。大枣富含蛋白质、脂肪、糖类、胡萝卜素、B族维生素、维生素C、维生素P以及钙、磷、铁和环磷酸腺苷等营养成分。其中维生素C的含量在果品中名列前茅,有维生素王之美称。
3桑椹又名桑葚,为桑科落叶乔木桑树的成熟果实,桑葚又叫桑果、桑枣,农人喜欢其成熟的鲜果食用,味甜汁多,是人们常食的水果之一。因桑树特殊的生长环境使桑果具有天然生长,无任何污染的特点,所以桑葚又被称为“民间圣果”。现代研究证实,桑葚果实中含有丰富的活性蛋白、维生素、氨基酸、胡萝卜素、矿物质、白藜芦醇、花青素等成份,营养是苹果的5~6倍,是葡萄的4倍,具有多种功效,被医学界誉为“二十一世纪的最佳保健果品”。常吃桑葚能显著提高人体免疫力,具有延缓衰老,美容养颜的功效。桑葚既可入食,又可入药,中医认为桑葚味甘酸,性微寒,入心、肝、肾经,为滋补强壮、养心益智佳果。具有,主治阴血不足而致的头晕目眩,耳鸣心悸,烦躁失眠,腰膝酸软,须发早白,消渴口干,大便干结等症。
4乌梅别名酸梅、黄仔、合汉梅、干枝梅,为蔷薇科落叶乔木植物梅Prunus mume的近成熟果实。果实含枸橼酸(citric acid),苹果酸(malic acid),草酸(oxalic acid),琥珀酸(succinic acid)和延胡索酸(fumaric acid)总酸量约4%-5.5%,以前两种有机酸的含量较多。还含5-羟甲基-2-糠醛(5-hydroxymethyl-2-furaldehyde),为无色油状物。所含挥发性成分,主要有苯甲醛(benzaldehyde)62.40%,4-松油烯醇(terpinen-4-ol)3.97%,苯甲醇(benzyl alcohol)3.97%和十六烷酸(hexadecanoic acid)4.55%。乌梅仁含苦杏仁苷(amygdalin)约0.5%,而梅仁含约4.3%。另有报道乌梅中还含苦味酸(picric acid)和超氧化物歧化酶(SOD)。具有保护肠胃、消除便秘、增进食欲、改善肝脏机能、防老化、清血、可软化血管,推迟血管硬化、孕妇止吐、解酒功能、增加能量、能预防疾病、防老抗衰及消除疲劳的功能。乌梅提取物也可作为天然防腐剂。
5蜂蜜蜂蜜味甘,入脾胃二经,能补中益气、润肠通便。蜂蜜对某些慢性病还有一定的疗效。常服蜂蜜对于心脏病、高血压、肺病、眼病、肝脏病、痢疾、便秘、贫血、神经系统疾病、胃和十二指肠溃疡病等都有良好的辅助医疗作用。春季气候多变,天气乍寒还暖,人就容易感冒。由于蜂蜜含有多种矿物质、维生素,还有清肺解毒的功能,故能增强人体免疫力,是春季最理想的滋补品。因此,在春季,如果每天能饮用1~2匙蜂蜜,以一杯温开水冲服或加牛奶服用,对身体有滋补的作用。
蜂蜜主要成分是果糖和葡萄糖,两者含量合计约占70%.尚含少量蔗糖、麦芽糖、糊精、树胶以及含氮化合物、有机酸、挥发油、色素、蜡、天然香料、植物残片(特别是花粉粒)、酵母、酶类、无机盐等。蜂蜜含有维生素A、维生素B1、维生素B2、维生素B6、维生素C、维生素D、维生素K、尼克酸、泛酸、叶酸、生物素、胆碱等.在含氮化合物中有蛋白质、胨、氨基酸等,尚含转化酶、过氧化氢酶、淀粉酶、氧化酶、还原酶等酶类,并含乙酰胆碱.灰分中主要含镁、钙、钾、钠、硫、磷以及微量元素铁、铜、锰、镍等.有机酸中含有柠檬酸、苹果酸、琥珀酸、乙酸、甲酸等。
一参三果配合蜂蜜使用制备的高丽红参蜜片具有强身健体的功能。
发明内容
1、一种高丽红参蜜片的加工工艺,其特征在于原辅料组成及配比为:
韩国产高丽鲜园参5年根100g、大枣提取物8-10g、桑椹提取物4-5g、乌梅提取物4-5g、明胶4-5g或卡拉胶4-5g、氯化钙0.1-0.3g、蜂蜜80-100g、麦芽糖80-100g、异麦芽低聚糖80-100g、水80-90mL。
2、一种高丽红参蜜片的加工工艺,其特征在于其生产工艺如下:
(1)挑选韩国产高丽鲜园参5年根100g并洗净;
(2)将(1)中洗净的韩国产高丽鲜园参切片,切片厚度为3-3.5mm,然后洗净;
(3)将(2)中的韩国产高丽鲜园参片用蒸锅进行蒸制,蒸制时间为从20℃逐渐升温至95℃需要30min,95℃保温1h-1.5h,焖30min至室温;
(4)将麦芽糖80-100g、异麦芽低聚糖80-100g放入80-90mL水中,得到糖溶液;
(5)将(4)中糖溶液、大枣提取物8-10g、桑椹提取物4-5g和乌梅提取物4-5g放入80-100g蜂蜜中,加热,搅拌均匀;
(6)将(3)中经蒸制过的韩国产高丽参片放到(5)中浸蜜,70-80℃水浴浸蜜8-12h,取出,沥干蜂蜜;
(7)将(6)中经浸过蜜的韩国产高丽参片用蒸锅进行第二次蒸制,95℃,蒸制时间为从20℃逐渐升温至95℃需要10min,95℃保温1h,焖30min至室温;
(8)将明胶4-5g或卡拉胶4-5g、氯化钙0.1-0.3g放到(5)溶液中,加热,搅拌均匀;
(9)将(7)中经第二次蒸制过的高丽参片放到(8)中浸蜜,70-80℃水浴浸蜜8-12h,取出,沥干蜂蜜;
(10)将(9)中经浸过蜜的韩国产高丽参片进行干燥:50℃,3-4h,得到表面不粘手的蜜片,软硬适中为宜,装袋或装瓶。
具体实施方式
本发明所述的涉及一种高丽红参蜜片的加工工艺包括以下实施例,下面的实施例可进一步说明本发明,但不以任何方式限制本发明。
实施例1:
1、一种高丽红参蜜片的加工工艺,其特征在于原辅料组成及配比为:
韩国产高丽鲜园参5年根100g、大枣提取物8g、桑椹提取物4g、乌梅提取物4g、明胶4g或卡拉胶4g、氯化钙0.1g、蜂蜜80g、麦芽糖80g、异麦芽低聚糖80g、水80mL。
2、一种高丽红参蜜片的加工工艺,其特征在于其生产工艺如下:
(1)挑选韩国产高丽鲜园参5年根100g并洗净;
(2)将(1)中洗净的韩国产高丽鲜园参切片,切片厚度为3mm,然后洗净;
(3)将(2)中的韩国产高丽鲜园参片用蒸锅进行蒸制,蒸制时间为从20℃逐渐升温至95℃需要30min,95℃保温1h,焖30min至室温;
(4)将麦芽糖80g、异麦芽低聚糖80g放入80mL水中,得到糖溶液;
(5)将(4)中糖溶液、大枣提取物8g、桑椹提取物4-5g和乌梅提取物4g放入80g蜂蜜中,加热,搅拌均匀;
(6)将(3)中经蒸制过的韩国产高丽参片放到(5)中浸蜜,70℃水浴浸蜜8h,取出,沥干蜂蜜;
(7)将(6)中经浸过蜜的韩国产高丽参片用蒸锅进行第二次蒸制,95℃,蒸制时间为从20℃逐渐升温至95℃需要10min,95℃保温1h,焖30min至室温;
(8)将明胶4g或卡拉胶4g、氯化钙0.1g放到(5)溶液中,加热,搅拌均匀;
(9)将(7)中经第二次蒸制过的高丽参片放到(8)中浸蜜,70℃水浴浸蜜8h,取出,沥干蜂蜜;
(10)将(9)中经浸过蜜的韩国产高丽参片进行干燥:50℃,3h,得到表面不粘手的蜜片,软硬适中为宜,装袋或装瓶。
实施例2:
1、一种高丽红参蜜片的加工工艺,其特征在于原辅料组成及配比为:
韩国产高丽鲜园参5年根100g、大枣提取物10g、桑椹提取物5g、乌梅提取物5g、明胶5g或卡拉胶5g、氯化钙0.3g、蜂蜜100g、麦芽糖100g、异麦芽低聚糖100g、水90mL。
2、一种高丽红参蜜片的加工工艺,其特征在于其生产工艺如下:
(1)挑选韩国产高丽鲜园参5年根100g并洗净;
(2)将(1)中洗净的韩国产高丽鲜园参切片,切片厚度为3.5mm,然后洗净;
(3)将(2)中的韩国产高丽鲜园参片用蒸锅进行蒸制,蒸制时间为从20℃逐渐升温至95℃需要30min,95℃保温1.5h,焖30min至室温;
(4)将麦芽糖100g、异麦芽低聚糖100g放入90mL水中,得到糖溶液;
(5)将(4)中糖溶液、大枣提取物10g、桑椹提取物5g和乌梅提取物5g放入100g蜂蜜中,加热,搅拌均匀;
(6)将(3)中经蒸制过的韩国产高丽参片放到(5)中浸蜜,80℃水浴浸蜜12h,取出,沥干蜂蜜;
(7)将(6)中经浸过蜜的韩国产高丽参片用蒸锅进行第二次蒸制,95℃,蒸制时间为从20℃逐渐升温至95℃需要10min,95℃保温1h,焖30min至室温;
(8)将明胶5g或卡拉胶5g、氯化钙0.3g放到(5)溶液中,加热,搅拌均匀;
(9)将(7)中经第二次蒸制过的高丽参片放到(8)中浸蜜,80℃水浴浸蜜12h,取出,沥干蜂蜜;
(10)将(9)中经浸过蜜的韩国产高丽参片进行干燥:50℃,4h,得到表面不粘手的蜜片,软硬适中为宜,装袋或装瓶。
Claims (2)
1.一种高丽红参蜜片的加工工艺,其特征在于原辅料组成及配比为:
韩国产高丽鲜园参5年根100g、大枣提取物8-10g、桑椹提取物4-5g、乌梅提取物4-5g、明胶4-5g或卡拉胶4-5g、氯化钙0.1-0.3g、蜂蜜80-100g、麦芽糖80-100g、异麦芽低聚糖80-100g、水80-90mL。
2.如权利要求1所述的一种高丽红参蜜片的加工工艺,其特征在于其生产工艺如下:
(1)挑选韩国产高丽鲜园参5年根100g并洗净;
(2)将(1)中洗净的韩国产高丽鲜园参切片,切片厚度为3-3.5mm,然后洗净;
(3)将(2)中的韩国产高丽鲜园参片用蒸锅进行蒸制,蒸制时间为从20℃逐渐升温至95℃需要30min,95℃保温1h-1.5h,焖30min至室温;
(4)将麦芽糖80-100g、异麦芽低聚糖80-100g放入80-90mL水中,得到糖溶液;
(5)将(4)中糖溶液、大枣提取物8-10g、桑椹提取物4-5g和乌梅提取物4-5g放入80-100g蜂蜜中,加热,搅拌均匀;
(6)将(3)中经蒸制过的韩国产高丽参片放到(5)中浸蜜,70-80℃水浴浸蜜8-12h,取出,沥干蜂蜜;
(7)将(6)中经浸过蜜的韩国产高丽参片用蒸锅进行第二次蒸制,95℃,蒸制时间为从20℃逐渐升温至95℃需要10min,95℃保温1h,焖30min至室温;
(8)将明胶4-5g或卡拉胶4-5g、氯化钙0.1-0.3g放到(5)溶液中,加热,搅拌均匀;
(9)将(7)中经第二次蒸制过的高丽参片放到(8)中浸蜜,70-80℃水浴浸蜜8-12h,取出,沥干蜂蜜;
(10)将(9)中经浸过蜜的韩国产高丽参片进行干燥:50℃,3-4h,得到表面不粘手的蜜片,软硬适中为宜,装袋或装瓶。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310596438.6A CN103564300B (zh) | 2013-11-22 | 2013-11-22 | 一种高丽红参蜜片的加工工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310596438.6A CN103564300B (zh) | 2013-11-22 | 2013-11-22 | 一种高丽红参蜜片的加工工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103564300A true CN103564300A (zh) | 2014-02-12 |
CN103564300B CN103564300B (zh) | 2015-04-08 |
Family
ID=50037694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310596438.6A Active CN103564300B (zh) | 2013-11-22 | 2013-11-22 | 一种高丽红参蜜片的加工工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103564300B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103976446A (zh) * | 2014-06-06 | 2014-08-13 | 通化百泉参业集团股份有限公司 | 一种红参液的加工方法 |
CN104172180A (zh) * | 2014-07-04 | 2014-12-03 | 陈帮龙 | 一种白首乌片及其制备方法 |
CN105028860A (zh) * | 2014-04-23 | 2015-11-11 | 都在男 | 利用棕榈粗糖浓缩液的红参切片、正果及其制备方法 |
CN106387260A (zh) * | 2016-09-08 | 2017-02-15 | 天津天元极生物科技有限公司 | 一种q弹即食红参片的加工方法 |
CN108125226A (zh) * | 2017-12-18 | 2018-06-08 | 白山市禄程农林科技有限公司 | 一种脆化参及其制备方法 |
CN108378362A (zh) * | 2018-04-24 | 2018-08-10 | 吉林大学 | 一种发酵糖参片的制备方法 |
CN109463516A (zh) * | 2018-11-13 | 2019-03-15 | 丁传波 | 一种新型红参蜜片的制备方法 |
CN109619573A (zh) * | 2019-03-01 | 2019-04-16 | 长沙每日滋养健康科技有限公司 | 一种即食高丽参蜜片的制造方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1069862A (zh) * | 1992-09-19 | 1993-03-17 | 包云喜 | 参硒蜜片的生产方法 |
CN1227075A (zh) * | 1998-02-25 | 1999-09-01 | 吉林省参茸办公室 | 美味洋参蜜片 |
CN1943419A (zh) * | 2006-10-25 | 2007-04-11 | 中国药科大学 | 一种保健食品及其制备方法 |
CN102018739A (zh) * | 2009-09-10 | 2011-04-20 | 吉林农业大学 | 一种人参或西洋参蜜片的生产方法 |
CN102266055A (zh) * | 2011-08-16 | 2011-12-07 | 越皓 | 一种人参膏及其制备方法 |
CN102488060A (zh) * | 2011-12-12 | 2012-06-13 | 康美新开河(吉林)药业有限公司 | 一种鲜人参蜜片及其制备方法 |
CN102511609A (zh) * | 2011-12-05 | 2012-06-27 | 芜湖蜂联有限公司 | 一种西洋参蜜饯的制备方法 |
CN103315117A (zh) * | 2013-06-05 | 2013-09-25 | 吉林省宏久生物科技股份有限公司 | 一种人参蛹虫草蜜饯的组方 |
-
2013
- 2013-11-22 CN CN201310596438.6A patent/CN103564300B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1069862A (zh) * | 1992-09-19 | 1993-03-17 | 包云喜 | 参硒蜜片的生产方法 |
CN1227075A (zh) * | 1998-02-25 | 1999-09-01 | 吉林省参茸办公室 | 美味洋参蜜片 |
CN1943419A (zh) * | 2006-10-25 | 2007-04-11 | 中国药科大学 | 一种保健食品及其制备方法 |
CN102018739A (zh) * | 2009-09-10 | 2011-04-20 | 吉林农业大学 | 一种人参或西洋参蜜片的生产方法 |
CN102266055A (zh) * | 2011-08-16 | 2011-12-07 | 越皓 | 一种人参膏及其制备方法 |
CN102511609A (zh) * | 2011-12-05 | 2012-06-27 | 芜湖蜂联有限公司 | 一种西洋参蜜饯的制备方法 |
CN102488060A (zh) * | 2011-12-12 | 2012-06-13 | 康美新开河(吉林)药业有限公司 | 一种鲜人参蜜片及其制备方法 |
CN103315117A (zh) * | 2013-06-05 | 2013-09-25 | 吉林省宏久生物科技股份有限公司 | 一种人参蛹虫草蜜饯的组方 |
Non-Patent Citations (2)
Title |
---|
王秀全等: "西洋参蜜片工艺流程的优选", 《吉林农业大学学报》 * |
良明: "一种鲜人参蜜片及其制做方法", 《今日科技》 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105028860A (zh) * | 2014-04-23 | 2015-11-11 | 都在男 | 利用棕榈粗糖浓缩液的红参切片、正果及其制备方法 |
CN103976446A (zh) * | 2014-06-06 | 2014-08-13 | 通化百泉参业集团股份有限公司 | 一种红参液的加工方法 |
CN103976446B (zh) * | 2014-06-06 | 2015-08-12 | 通化百泉参业集团股份有限公司 | 一种红参液的加工方法 |
CN104172180A (zh) * | 2014-07-04 | 2014-12-03 | 陈帮龙 | 一种白首乌片及其制备方法 |
CN106387260A (zh) * | 2016-09-08 | 2017-02-15 | 天津天元极生物科技有限公司 | 一种q弹即食红参片的加工方法 |
CN106387260B (zh) * | 2016-09-08 | 2020-01-24 | 江西康一参生物科技有限公司 | 一种q弹即食红参片的加工方法 |
CN108125226A (zh) * | 2017-12-18 | 2018-06-08 | 白山市禄程农林科技有限公司 | 一种脆化参及其制备方法 |
CN108378362A (zh) * | 2018-04-24 | 2018-08-10 | 吉林大学 | 一种发酵糖参片的制备方法 |
CN109463516A (zh) * | 2018-11-13 | 2019-03-15 | 丁传波 | 一种新型红参蜜片的制备方法 |
CN109619573A (zh) * | 2019-03-01 | 2019-04-16 | 长沙每日滋养健康科技有限公司 | 一种即食高丽参蜜片的制造方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103564300B (zh) | 2015-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103564300B (zh) | 一种高丽红参蜜片的加工工艺 | |
CN103719660B (zh) | 一种韩国高丽红参切片蜜片的加工工艺 | |
CN103725572B (zh) | 一种高丽红参酒的制备方法 | |
CN107691695A (zh) | 一种山黄皮红茶的制备方法 | |
CN103689743B (zh) | 一种高丽红参桑椹饮料的制备方法 | |
CN103725467B (zh) | 一种高丽参红葡萄酒的制备方法 | |
CN104770714A (zh) | 一种西洋参蜜片的加工工艺 | |
CN105942068A (zh) | 一种高丽红参汤的制备方法 | |
CN103695275B (zh) | 一种双参酒的制备方法 | |
CN103704458B (zh) | 一种高丽参蜜片的加工工艺 | |
CN107950850A (zh) | 一种益胃生津、滋阴清热的石斛固体饮料的制备方法及应用 | |
CN107691718A (zh) | 一种竹叶红茶的制备方法 | |
CN103704712B (zh) | 一种高丽红参含片的制备方法 | |
CN105524805A (zh) | 一种高丽红参猴头菇酒的制备方法 | |
CN103750425B (zh) | 一种高丽红参罗汉果汤的制备方法 | |
CN105077501A (zh) | 一种青年女性用减肥饮料 | |
CN103689602B (zh) | 一种高丽红参口服液的制备方法 | |
CN103564572A (zh) | 一种高丽红参汤的制备方法 | |
CN103689742B (zh) | 一种高丽红参无花果饮料的制备方法 | |
CN103719499B (zh) | 一种高丽红参茶的制备方法 | |
CN102827731B (zh) | 保健酒的制备工艺 | |
CN102835700A (zh) | 具有润肺、养胃功效的保健饮料及其制作方法 | |
CN103652255B (zh) | 一种韩国高丽红参蜜枣的加工工艺 | |
CN105341579A (zh) | 一种提高免疫力的保健饮料及其制备方法 | |
KR101067251B1 (ko) | 산양산삼을 함유하는 조성물 및 구증구포(九蒸九曝)를 이용하여 이를 제조하는 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PP01 | Preservation of patent right |
Effective date of registration: 20190905 Granted publication date: 20150408 |
|
PP01 | Preservation of patent right | ||
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20210905 Granted publication date: 20150408 |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20211025 Granted publication date: 20150408 |
|
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20231025 Granted publication date: 20150408 |